Print

Training shall be provided to all employees with occupational exposure as follows: [5199(i)(2)]

  • At the time of initial assignment to tasks where occupational exposure may take place.
  • At least annually thereafter, not to exceed 12 months from the previous training.
  • When changes, such as introduction of new engineering or work practice controls, modification of tasks or procedures or institution of new tasks or procedures, affect the employee's occupational exposure or control measures. The additional training may be limited to addressing the new exposures or control measures.

Training shall include the following elements: [5199(i)(4)]

  • An accessible copy of the regulatory text of 8CCR 5199 and an explanation of its contents. [5199(i)(4)(A)]
  • A general explanation of ATDs including the signs and symptoms of ATDs that require further medical evaluation. [5199(i)(4)(B)]
  • An explanation of the modes of transmission ATPs-L. [5199(i)(4)(C)]
  • An explanation of the Stanford University ATD Program and the local Biosafety Plan, and the means by which the employee can obtain a copy of these written plans and how they can provide input as to its effectiveness. [5199(i)(4)(D)]
  • An explanation of the appropriate methods for recognizing tasks and other activities that may expose the employee to ATPs-L. [5199(i)(4)(E)]
  • An explanation of the use and limitations of methods that will prevent or reduce exposure to ATPs-L including appropriate engineering and work practice controls, decontamination and disinfection procedures, and personal and respiratory protective equipment. [5199(i)(4)(F)]
  • An explanation of the basis for selection of personal protective equipment, its uses and limitations, and the types, proper use, location, removal, handling, cleaning, decontamination and disposal of the items of personal protective equipment employees will use. [5199(i)(4)(G)]
  • A description of the University’s TB surveillance procedures, including the information that persons who are immune-compromised may have a false negative test for latent TB infection (LTBI).

EXCEPTION: Laboratories do not need to include training on surveillance for LTBI if M. tuberculosis containing materials are not reasonable anticipated to be present in the laboratory. [5199(i)(4)(H)]

  • Information on the vaccines made available by the employer, including information on their efficacy, safety, method of administration, the benefits of being vaccinated, and that the vaccine and vaccination will be offered free of charge. [5199(i)(4)(J)]
  • An explanation of the procedure to follow if an exposure incident occurs, including the method of reporting the incident, the medical follow-up that will be made available, and post-exposure evaluation. [5199(i)(4)(K)]

The training program shall include an opportunity for interactive questions and answers with a person who is knowledgeable in the subject matter of the training as it relates to the workplace that the training addresses and who is also knowledgeable in the Stanford University ATD Program and the local biosafety plan.